Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$21.37
-3.39%
Mkt Cap $20.45B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 23, 2026 | $56.78M | — | — | -$0.10 | -$0.29 | -182.54% | — | — |
| Q4 2025 Oct 20, 2025 | $76.50M | — | — | -$0.18 | -$0.31 | -76.37% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.09 | -$0.76 | -736.91% | — | — |
| Q2 2025 May 1, 2025 | — | — | — | -$0.09 | -$0.09 | +3.25% | — | — |
| Q1 2025 Feb 24, 2025 | — | — | — | -$0.08 | -$0.08 | +2.21% | — | — |
| Q4 2024 Oct 30, 2024 | — | — | — | -$0.07 | -$0.08 | -14.29% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.06 | -$0.05 | +16.67% | — | — |
| Q2 2024 May 1, 2024 | — | — | — | -$0.06 | -$0.06 | +0.00% | — | — |
| Q1 2024 Feb 20, 2024 | — | — | — | — | -$0.04 | — | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | — | -$0.03 | — | — | — |
| Q3 2023 Aug 9, 2023 | — | $235.00K | — | — | -$0.02 | — | — | — |
| Q2 2023 May 11, 2023 | — | — | — | — | -$0.06 | — | — | — |
| Q1 2023 Mar 9, 2023 | — | $705 | — | -$0.26 | -$0.07 | +73.08% | — | — |
| Q4 2022 Nov 9, 2022 | — | $220.00K | — | -$0.26 | -$0.14 | +46.15% | — | — |
| Q3 2022 Aug 11, 2022 | — | $235.00K | — | -$0.27 | -$0.17 | +37.04% | — | — |
| Q2 2022 May 11, 2022 | — | $250.00K | — | -$0.28 | -$0.22 | +21.43% | — | — |
| Q1 2022 Mar 17, 2022 | — | $251.00K | — | -$0.27 | -$0.28 | -3.70% | — | — |
| Q4 2021 Nov 15, 2021 | $1.71K | $1.31M | +76629.19% | -$0.29 | -$0.20 | +31.03% | — | — |
| Q3 2021 Aug 11, 2021 | $57.00K | $57.00K | +0.00% | -$0.18 | -$0.27 | -50.00% | — | — |
| Q2 2021 May 17, 2021 | — | $192.00K | — | — | -$1.05 | — | — | — |